Breast cancer treatment delays in a majority minority community: is there a difference?
Breast Cancer Treatment Delays in a Majority Minority Community: Is There a Difference?
Breast Cancer Treatment Delays in a Majority Minority Community: Is There a Difference?
Ismail Jatoi, MD, PhD, FACS Surgical Oncology, Breast Surgery
Drug shows promise for treating brain tumors resulting from breast cancer, UT Health San Antonio trial reports
A drug effective in treating breast cancer shows new promise in addressing breast cancer with brain metastases or recurrent glioblastoma, as reported by results of a prospective window-of-opportunity trial at the University of Texas Health Science Center at San Antonio (UT Health San Antonio). The window trial, in which patients agreed to receive a novel […]
Targeting aberrant replication and DNA repair events for treating breast cancers
Demonstration of a Novel Approach Using Surface-Image Guidance to Improve Delivery of Breast Radiotherapy
CTMS#: 18-0135
The first goal of this project is to validate the superiority of semi-permanent marks used in conjunction with specialized light-based surface imaging (SIGRT) in an effort to phase out the use of permanent tattoos for the investigator's patients. The secondary goal of this project is to validate the superiority of specialized light-based surface imaging for daily radiation set-up compared to standard-of-care imaging methods using ionizing radiation, such as weekly port films or cone-beam CT (CBCT) scans during a radiation therapy course for breast cancer.